YAL
RLAY icon

Your Advocates Ltd’s Relay Therapeutics RLAY Stock Holding History

Your Advocates Ltd’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$995 – 238
2026
Q1 		$995 Hold
100
– – ﹤0.01% 196
2025
Q4 		$846 Hold
100
– – ﹤0.01% 202
2025
Q3 		$522 Hold
100
– – ﹤0.01% 193
2025
Q2 		$346 Hold
100
– – ﹤0.01% 181
2025
Q1 		$262 Hold
100
– – ﹤0.01% 190
2024
Q4 		$412 Hold
100
– – ﹤0.01% 187
2024
Q3 		$708 Hold
100
– – ﹤0.01% 197
2024
Q2 		$652 Hold
100
– – ﹤0.01% 201
2024
Q1 		$830 Hold
100
– – ﹤0.01% 197
2023
Q4 		$1.1K Hold
100
– – ﹤0.01% 191
2023
Q3 		$841 Hold
100
– – ﹤0.01% 227
2023
Q2 		$1.26K Hold
100
– – ﹤0.01% 231
2023
Q1 		$1.65K Hold
100
– – ﹤0.01% 183
2022
Q4 		$1.49K Hold
100
– – ﹤0.01% 172
2022
Q3 		$2K Hold
100
– – ﹤0.01% 155
2022
Q2 		$2K Hold
100
– – ﹤0.01% 162
2022
Q1 		$3K Hold
100
– – ﹤0.01% 163
2021
Q4 		$3K Hold
100
– – ﹤0.01% 156
2021
Q3 		$3K Hold
100
– – ﹤0.01% 158
2021
Q2 		$4K Hold
100
– – ﹤0.01% 105
2021
Q1 		$3K Buy
+100
New +$4.34K ﹤0.01% 112

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Your Advocates Ltd's RLAY Position: Q2 2026 in Review

Your Advocates Ltd sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 100 shares — an estimated $995 sold.

Your Advocates Ltd first reported a position in RLAY in Q1 2021 and held it in 21 quarters. The position peaked at $4K in Q2 2021. 260 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Your Advocates Ltd reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Your Advocates Ltd sold 100 Relay Therapeutics shares in Q2 2026, an estimated $995.
  • Your Advocates Ltd first reported a position in Relay Therapeutics in Q1 2021 and held it in 21 quarters.
  • Your Advocates Ltd's Relay Therapeutics position peaked at $4K in Q2 2021.
  • 260 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Your Advocates Ltd's 13F filing for Q2 2026, filed 5 Aug 2026.